These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 38961885)

  • 21. Supramolecular cancer nanotheranostics.
    Zhou J; Rao L; Yu G; Cook TR; Chen X; Huang F
    Chem Soc Rev; 2021 Feb; 50(4):2839-2891. PubMed ID: 33524093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folic acid magnetic nanotheranostics for delivering doxorubicin: Toxicological and biocompatibility studies on Zebrafish embryo and larvae.
    Igartúa DE; Azcona PL; Martinez CS; Alonso SDV; Lassalle VL; Prieto MJ
    Toxicol Appl Pharmacol; 2018 Nov; 358():23-34. PubMed ID: 30205093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease.
    Jiang R; Lou L; Shi W; Chen Y; Fu Z; Liu S; Sok T; Li Z; Zhang X; Yang J
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity.
    Luo X
    Environ Res; 2023 Dec; 238(Pt 2):116989. PubMed ID: 37633635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-modulated self-assembly as a versatile strategy for tumor supramolecular nanotheranostics.
    Li S; Zou Q; Xing R; Govindaraju T; Fakhrullin R; Yan X
    Theranostics; 2019; 9(11):3249-3261. PubMed ID: 31244952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supramolecular Nanotheranostics.
    Chen X; Zheng G; Cheng J; Yang YY
    Theranostics; 2019; 9(11):3014-3016. PubMed ID: 31244939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
    Gupta U; Maity D; Sharma VK
    Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review.
    Al-Thani AN; Jan AG; Abbas M; Geetha M; Sadasivuni KK
    Life Sci; 2024 Sep; 352():122899. PubMed ID: 38992574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs.
    Wong XY; Sena-Torralba A; Álvarez-Diduk R; Muthoosamy K; Merkoçi A
    ACS Nano; 2020 Mar; 14(3):2585-2627. PubMed ID: 32031781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Aspects of Anthracycline Cardiotoxicity.
    Russo M; Della Sala A; Tocchetti CG; Porporato PE; Ghigo A
    Curr Treat Options Oncol; 2021 Feb; 22(2):18. PubMed ID: 33547494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxorubicin-mediated cardiac dysfunction: Revisiting molecular interactions, pharmacological compounds and (nano)theranostic platforms.
    Li X
    Environ Res; 2023 Oct; 234():116504. PubMed ID: 37356521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy.
    Lorkowski ME; Atukorale PU; Ghaghada KB; Karathanasis E
    Adv Healthc Mater; 2021 Mar; 10(5):e2001044. PubMed ID: 33225633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiotoxicity of drugs used in oncology].
    Poprach A; Petráková K; Vyskocil J; Lakomý R; Nemecek R; Kocák I; Kocáková I; Vyzula R
    Klin Onkol; 2008; 21(5):288-93. PubMed ID: 19202960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guarding the heart: How SGLT-2 inhibitors protect against chemotherapy-induced cardiotoxicity: SGLT-2 inhibitors and chemotherapy-induced cardiotoxicity.
    Vafa RG; Sabahizadeh A; Mofarrah R
    Curr Probl Cardiol; 2024 Mar; 49(3):102350. PubMed ID: 38128634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy.
    Su X; Zhang X; Liu W; Yang X; An N; Yang F; Sun J; Xing Y; Shang H
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):929-942. PubMed ID: 34375726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent nanotheranostic approaches in cancer research.
    Gupta D; Roy P; Sharma R; Kasana R; Rathore P; Gupta TK
    Clin Exp Med; 2024 Jan; 24(1):8. PubMed ID: 38240834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity.
    Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F
    Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine.
    Canetta E
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.